Thermo Fisher Scientific | TMO - Net Income

Stock Price
545.98
Daily Change
3.62 0.67%
Monthly
-11.53%
Yearly
-4.46%
Q1 Forecast
560.79

Thermo Fisher Scientific reported $1.96B in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Abbott USD 1.78B 132M Dec/2025
Agilent USD 434M 98M Sep/2025
Becton, Dickinson and Co. USD 493M 81M Sep/2025
Bio Techne USD 38.01M 176K Dec/2025
Bio-Rad Laboratories USD 317.8M 253.8M Jun/2025
Boston Scientific USD 672M 83M Dec/2025
Bruker USD -62.4M 70M Sep/2025
Charles River Laboratories USD 54.42M 2.1M Sep/2025
Danaher USD 1.2B 289M Dec/2025
Dentsply International USD -427M 382M Sep/2025
Edwards Lifesciences USD 291.1M 42.1M Sep/2025
Exact Sciences USD -19.59M 18.41M Sep/2025
General Electric Aerospace USD 2.54B 384M Dec/2025
Henry Schein USD 101M 15M Sep/2025
Hologic USD 179.1M 8.2M Dec/2025
Illumina USD 334M 184M Dec/2025
Intuitive Surgical USD 794.8M 90.4M Dec/2025
IQVIA Holdings USD 514M 183M Dec/2025
Laboratory Of America USD 261.1M 23.2M Sep/2025
Medtronic USD 1.37B 334M Sep/2025
Mettler Toledo International USD 285.76M 68.27M Dec/2025
Myriad Genetics USD -27.4M 303.1M Sep/2025
Olympus JPY 20.2B 11.2B Sep/2025
Quest Diagnostics USD 245M 37M Sep/2025
Repligen USD 14.91M 44K Sep/2025
Revvity USD 46.65M 7.3M Sep/2025
Stryker USD 849M 10M Dec/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025
Veracyte USD 19.14M 20.12M Sep/2025
Waters USD 148.92M 1.81M Sep/2025
Zimmer Biomet Holdings USD 230.9M 78.1M Sep/2025